Withholding stereotactic radiotherapy in elderly patients with stage i non-small cell lung cancer and co-existing COPD is not justified: Outcomes of a markov model analysis

Radiotherapy and Oncology

Volumn 99, Issue 2, 2011, Pages 161-165

  Louie, Alexander V ^a   Rodrigues, George ^a,b,e   Hannouf, Malek ^b   Lagerwaard, Frank ^c   Palma, David ^a,c   Zaric, Gregory S ^b,d   Haasbeek, Cornelis ^c   Senan, Suresh ^c  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e NONE   (Canada)

Author keywords

Best supportive care; Geriatric oncology; Lung cancer; Markov model; SBRT

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; HIDDEN MARKOV MODEL; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE MONTH; QUALITY OF LIFE; STEREOTACTIC BODY RADIATION THERAPY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MARKOV CHAINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY-ADJUSTED LIFE YEARS; RADIOSURGERY; SURVIVAL RATE; WITHHOLDING TREATMENT;

EID: 79958180639     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.04.005     Document Type: Article

References (53)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. D.J. Raz, J.A. Zell, S.H. Ou, D.R. Gandara, H. Anton-Culver, and D.M. Jablons Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199 (Pubitemid 47068221)
3. J.P. Wisnivesky, M. Bonomi, C. Henschke, M. Iannuzzi, and T. McGinn Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer Chest 128 2005 1461 1467 (Pubitemid 41324433)
4. R. Rami-Porta, D. Ball, J. Crowley, D.J. Giroux, J. Jett, and W.D. Travis The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593 602 (Pubitemid 47171780)
5. N. Martini, M.S. Bains, M.E. Burt, M.F. Zakowski, P. McCormack, and V.W. Rusch Incidence of local recurrence and second primary tumors in resected stage I lung cancer J Thorac Cardiovasc Surg 109 1995 120 129
6. N.P. Rowell, and C.J. Williams Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review Thorax 56 2001 628 638 (Pubitemid 32706145)
7. R.S. Loganathan, D.E. Stover, W. Shi, and E. Venkatraman Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer Chest 129 2006 1305 1312
8. T.K. Owonikoko, C.C. Ragin, C.P. Belani, A.B. Oton, W.E. Gooding, and E. Taioli Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database J Clin Oncol 25 2007 5570 5577
9. S. Tyldesley, J. Zhang-Salomons, P.A. Groome, S. Zhou, K. Schulze, and L.F. Paszat Association between age and the utilization of radiotherapy in Ontario Int J Radiat Oncol Biol Phys 47 2000 469 480 (Pubitemid 30236390)
10. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001:CD002935.
11. C.L. Ong, W.F. Verbakel, J.P. Cuijpers, B.J. Slotman, F.J. Lagerwaard, and S. Senan Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques Radiother Oncol 97 2010 437 442
12. C.L. Ong, D. Palma, W.F. Verbakel, B.J. Slotman, and S. Senan Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT). Planning considerations and early toxicity Radiother Oncol 97 2010 431 436
13. J.P. Cuijpers, M. Dahele, S. Senan, and W.F. Verbakel Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data Radiother Oncol 94 2010 224 228
14. K. Han, P. Cheung, P.S. Basran, I. Poon, L. Yeung, and F. Lochray A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors Radiother Oncol 95 2010 103 108
15. A. Chi, Z. Liao, N.P. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications Radiother Oncol 94 2010 1 11
16. R.D. Timmerman Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who's down for the count? J Clin Oncol 28 2010 907 909
17. C.J. Haasbeek, F.J. Lagerwaard, M.E. Antonisse, B.J. Slotman, and S. Senan Stage I nonsmall cell lung cancer in patients aged > or = 75 years: outcomes after stereotactic radiotherapy Cancer 116 2010 406 414
18. R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, and S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256 1276 (Pubitemid 32378468)
19. M. Henderson, R. McGarry, C. Yiannoutsos, A. Fakiris, D. Hoopes, and M. Williams Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 404 409
20. K.L. Stephans, T. Djemil, C.A. Reddy, S.M. Gajdos, M. Kolar, and M. Machuzak Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients J Thorac Oncol 4 2009 838 844
21. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
22. N. Kopek, M. Paludan, J. Petersen, A.T. Hansen, C. Grau, and M. Høyer Co-morbidity indexpredicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Radiother Oncol 93 2009 402 407
23. P. Baumann, J. Nyman, M. Hoyer, G. Gagliardi, I. Lax, and B. Wennberg Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer-a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
24. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery Thorax 56 2001 89 108
25. L.F. Hutchins, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and K.S. Albain Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 1999 2061 2067 (Pubitemid 30035956)
26. G. Rodrigues, A.V. Louie, M. Hannouf, G. Zaric, D. Palma, and J. Mocanu Stereotactic body radiotherapy versus surgery for stage I NSCLC: a Markov model-based decision analysis J Thorac Oncol 5 2010 S68 1-5-2010
27. F.J. Lagerwaard, C.J. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
28. V. Cangemi, P. Volpino, N. D'Andrea, F. Chiarotti, R. Tomassini, and G. Piat Results of surgical treatment of stage IIIA non-small cell lung cancer Eur J Cardiothorac Surg 9 1995 352 359
29. K. Furuse, M. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada, and S. Kudoh Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699 (Pubitemid 29415225)
30. X. Qiao, O. Tullgren, I. Lax, F. Sirzen, and R. Lewensohn The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11 (Pubitemid 36765477)
31. Surveillance, Epidemiology, End-Results: SEER Cancer Statistics Review 1973-2006. National Cancer Institute Section 17-Lung, 1973-2006; 2006.
32. A. Szende, N.K. Leidy, E. Stahl, and K. Svensson Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D Qual Life Res 18 2009 267 272
33. F.J. Papatheofanis Utility evaluations for Markov states of lung cancer for PET-based disease management Q J Nucl Med 44 2000 186 190 (Pubitemid 30623523)
34. D.G. Fryback, and W.F. Lawrence Jr Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments Med Decis Making 17 1997 276 284 (Pubitemid 27282028)
35. W.B. van den Hout, G.W. Kramer, E.M. Noordijk, and J.W. Leer Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer J Natl Cancer Inst 98 2006 1786 1794 (Pubitemid 46017930)
36. S.O. Rogers Jr., S.W. Gray, M.B. Landrum, C.N. Klabunde, K.L. Kahn, and R.H. Fletcher Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity Ann Surg Oncol 17 2010 1581 1588
37. D.V.O. Palma, F.J. Lagerwaard, J. Belderbos, B. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I NSCLC: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
38. R.C. McGarry, G. Song, P. des Rosiers, and R. Timmerman Observation-only management of early stage, medically inoperable lung cancer: poor outcome Chest 121 2002 1155 1158 (Pubitemid 34280436)
39. A.S. Chadha, A.K. Ganti, J.S. Sohi, A.E. Sahmoun, and S.A. Mehdi Survival in untreated early stage non-small cell lung cancer Anticancer Res 25 2005 3517 3520 (Pubitemid 41105233)
40. C.I. Henschke, J.P. Wisnivesky, D.F. Yankelevitz, and O.S. Miettinen Small stage I cancers of the lung: genuineness and curability Lung Cancer 39 2003 327 330 (Pubitemid 36284731)
41. S.J. Swensen, M.D. Silverstein, D.M. Ilstrup, C.D. Schleck, and E.S. Edell The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules Arch Intern Med 157 1997 849 855 (Pubitemid 28337035)
42. G.J. Herder, H. van Tinteren, R.P. Golding, P.J. Kostense, E.F. Comans, and E.F. Smit Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography Chest 128 2005 2490 2496 (Pubitemid 41507599)
43. van der Voort, van Zyp NC, Prevost JB, van der Holt B, Braat C, van Klaveren RJ, Pattynama PM, et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009.
44. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
45. C.M. Mery, A.N. Pappas, R. Bueno, Y.L. Colson, P. Linden, and D.J. Sugarbaker Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database Chest 128 2005 237 245 (Pubitemid 40994479)
46. K. Sigel, M. Bonomi, S. Packer, and J. Wisnivesky Effect of age on survival of clinical stage I non-small-cell lung cancer Ann Surg Oncol 16 2009 1912 1917
47. M. Kamiyoshihara, O. Kawashima, S. Ishikawa, and Y. Morishita Long-term results after pulmonary resection in elderly patients with non-small cell lung cancer J Cardiovasc Surg (Torino) 41 2000 483 486 (Pubitemid 30450024)
48. B. Goodgame, A. Viswanathan, J. Zoole, F. Gao, C.R. Miller, and J. Subramanian Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients J Thorac Oncol 4 2009 1370 1374
49. D.A. Palma, S. Tyldesley, F. Sheehan, I.G. Mohamed, S. Smith, and E. Wai Stage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment? J Thorac Oncol 5 2010 818 824
50. J.W. Powell, E. Dexter, E.M. Scalzetti, and J.A. Bogart Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials Lancet Oncol 10 2009 885 894
51. Y. Nagata, M. Hiraoka, T. Mizowaki, Y. Narita, Y. Matsuo, and Y. Norihisa Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group Int J Radiat Oncol Biol Phys 75 2009 343 347
52. B.J. McNeil, R. Weichselbaum, and S.G. Pauker Fallacy of the five-year survival in lung cancer N Engl J Med 299 1978 1397 1401 (Pubitemid 9092483)
53. R.C. Viney, M.J. Boyer, M.T. King, P.M. Kenny, C.A. Pollicino, and J.M. McLean Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer J Clin Oncol 22 2004 2357 2362 (Pubitemid 41115392)